Asia Pacific Hypodermic Needles Market Share by Size and Growth 2028

The Asia Pacific hypodermic needles market is expected to reach US$ 1,092.6 million by 2028 from US$ 668.7 million in 2021. The market is estimated to grow at a CAGR of 7.3% from 2021–2028.

As per the CDC, direct costs for testing and treatment can range from US$ 500 to US$ 3,000 per injury. Safety needles are designed to deliver drugs by maintaining safety features for avoiding needlestick injuries. Safety-engineered devices protect healthcare workers from avoidable needlestick injury and risk of infection with Hepatitis or even HIV. Introducing safety devices is essential to remove unnecessary risks from the healthcare professional’s working environment. The demand for safety hypodermic needles is likely to increase with the rising popularity of safety syringes and needles supported by the Needlestick Safety and Prevention Act that reduces unnecessary costs and needlestick injuries. The enforcement of such legislation will stimulate demand for Asia Pacific hypodermic needles market in the coming years.

The demand for hypodermic needles is growing continuously as the demand for the vaccine is increasing for COVID-19. Thus, the market players are actively involved in the market development activities in the COVID-19 pandemic. For instance, In April 2021, Misawa Medical Industry Co., Ltd. has developed "Low Dead Space Needles," which can reduce the quantity of medicinal liquid left in the syringe and will begin selling them in Japan on April 1, 2021. This eliminates the need for a particular syringe and reduces the "dead space" in which the liquid lingers in the syringe. Furthermore, one vial of the new COVID vaccines developed by Pfizer Inc can offer six injections. In June 2020, Misawa Medical Industry Co., Ltd. extended its needle manufacturing facilities, boosting its annual production capacity from 1.9 billion to 3 billion pieces. The company is currently strengthening the vaccine needle production system while employing other product production lines, and the company will continue to make efforts to make vaccination easier.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the hypodermic needles market. The Asia Pacific hypodermic needles market is expected to grow at a good CAGR during the forecast period.

Asia Pacific Hypodermic Needles Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Hypodermic Needles Market Segmentation

By Type

Safety Needles
- Retractable Needles
- Non-retractable Needles
Non-safety Needles

By Application

Drug Delivery
Vaccination
Blood Specimen Collection

By End User

Hospitals and Clinics
Diagnostic Centers
Home Health Care

By Usage

Disposable
Reusable

By Country

Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific

Companies Mentioned

Terumo Corporation
BD
B. Braun Melsungen AG
Catalent Inc
Cardinal Health Inc
Vygon
Barber of Sheffield
Nipro Corp.

Asia Pacific Hypodermic Needles Market Strategic Insights

Get more information on this report

Asia Pacific Hypodermic Needles Market Segmentation Analysis

Asia Pacific Hypodermic Needles Market Report Highlights

Asia Pacific Hypodermic Needles Report Scope

Report Attribute	Details
Market size in 2021	US$ 668.7 Million
Market Size by 2028	US$ 1,092.6 Million
CAGR (2021 - 2028)	7.3%
Historical Data	2019-2020
Forecast period	2022-2028
Segments Covered	By Type Safety Needles Non-safety Needles By Application Drug Delivery Vaccination Blood Specimen Collection By End-Users Diagnostic Centers Hospitals and Clinics Home Health Care By Usage Disposable Reusable
Regions and Countries Covered	Asia-Pacific China India Japan Australia Rest of Asia-Pacific
Market leaders and key company profiles	Terumo Corporation BD B. Braun Melsungen AG Catalent Inc Cardinal Health Inc Vygon Barber of Sheffield Nipro Corp.